Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Regulation of VH replacement by B cell receptor-mediated signaling in human immature B cells.

Liu J, Lange MD, Hong SY, Xie W, Xu K, Huang L, Yu Y, Ehrhardt GR, Zemlin M, Burrows PD, Su K, Carter RH, Zhang Z.

J Immunol. 2013 Jun 1;190(11):5559-66. doi: 10.4049/jimmunol.1102503. Epub 2013 Apr 29.

2.

Lymphotoxin α1β2 expression on B cells is required for follicular dendritic cell activation during the germinal center response.

Myers RC, King RG, Carter RH, Justement LB.

Eur J Immunol. 2013 Feb;43(2):348-59. doi: 10.1002/eji.201242471. Epub 2012 Dec 5.

3.

B lymphocytes are resistant to death receptor 5-induced apoptosis.

Crowder RN, Zhao H, Chatham WW, Zhou T, Carter RH.

Clin Immunol. 2011 Apr;139(1):21-31. doi: 10.1016/j.clim.2010.12.006. Epub 2011 Jan 28.

4.

Marginal zone B cells regulate antigen capture by marginal zone macrophages.

You Y, Myers RC, Freeberg L, Foote J, Kearney JF, Justement LB, Carter RH.

J Immunol. 2011 Feb 15;186(4):2172-81. doi: 10.4049/jimmunol.1002106. Epub 2011 Jan 21.

5.
6.

Cutting edge: Primary and secondary effects of CD19 deficiency on cells of the marginal zone.

You Y, Zhao H, Wang Y, Carter RH.

J Immunol. 2009 Jun 15;182(12):7343-7. doi: 10.4049/jimmunol.0804295.

7.

Germinal center structure and function: lessons from CD19.

Carter RH, Myers R.

Semin Immunol. 2008 Feb;20(1):43-8. doi: 10.1016/j.smim.2007.12.007. Epub 2008 Feb 19. Review.

8.

Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice.

Hsu HC, Yang P, Wang J, Wu Q, Myers R, Chen J, Yi J, Guentert T, Tousson A, Stanus AL, Le TV, Lorenz RG, Xu H, Kolls JK, Carter RH, Chaplin DD, Williams RW, Mountz JD.

Nat Immunol. 2008 Feb;9(2):166-75. Epub 2007 Dec 23.

PMID:
18157131
9.

Overexpression of activation-induced cytidine deaminase in B cells is associated with production of highly pathogenic autoantibodies.

Hsu HC, Wu Y, Yang P, Wu Q, Job G, Chen J, Wang J, Accavitti-Loper MA, Grizzle WE, Carter RH, Mountz JD.

J Immunol. 2007 Apr 15;178(8):5357-65.

10.

B cells in health and disease.

Carter RH.

Mayo Clin Proc. 2006 Mar;81(3):377-84. Review.

PMID:
16529141
11.

Expression and occupancy of BAFF-R on B cells in systemic lupus erythematosus.

Carter RH, Zhao H, Liu X, Pelletier M, Chatham W, Kimberly R, Zhou T.

Arthritis Rheum. 2005 Dec;52(12):3943-54.

13.

B cell signalling as therapeutic target.

Carter RH.

Ann Rheum Dis. 2004 Nov;63 Suppl 2:ii65-ii66. Review. No abstract available.

14.

B cells: new ways to inhibit their function in rheumatoid arthritis.

Carter RH.

Curr Rheumatol Rep. 2004 Oct;6(5):357-63. Review.

PMID:
15355748
15.

Control of spontaneous B lymphocyte autoimmunity with adenovirus-encoded soluble TACI.

Liu W, Szalai A, Zhao L, Liu D, Martin F, Kimberly RP, Zhou T, Carter RH.

Arthritis Rheum. 2004 Jun;50(6):1884-96.

16.

Binding of cytoplasmic proteins to the CD19 intracellular domain is high affinity, competitive, and multimeric.

Brooks SR, Kirkham PM, Freeberg L, Carter RH.

J Immunol. 2004 Jun 15;172(12):7556-64.

17.

B cell signaling is regulated by induced palmitoylation of CD81.

Cherukuri A, Carter RH, Brooks S, Bornmann W, Finn R, Dowd CS, Pierce SK.

J Biol Chem. 2004 Jul 23;279(30):31973-82. Epub 2004 May 25.

18.

Signaling by the CD19/CD21 complex on B cells.

Carter RH, Barrington RA.

Curr Dir Autoimmun. 2004;7:4-32. Review.

PMID:
14719373
19.

A novel polymorphism in the Fcgamma receptor IIB (CD32B) transmembrane region alters receptor signaling.

Li X, Wu J, Carter RH, Edberg JC, Su K, Cooper GS, Kimberly RP.

Arthritis Rheum. 2003 Nov;48(11):3242-52.

20.

Phage N4 RNA polymerase II recruitment to DNA by a single-stranded DNA-binding protein.

Carter RH, Demidenko AA, Hattingh-Willis S, Rothman-Denes LB.

Genes Dev. 2003 Sep 15;17(18):2334-45.

21.

Upcoming biologic agents for the treatment of rheumatic diseases.

Shanahan JC, Moreland LW, Carter RH.

Curr Opin Rheumatol. 2003 May;15(3):226-36. Review.

PMID:
12707575
22.

A role for BLyS in tissue inflammation?

Carter RH.

Arthritis Rheum. 2003 Apr;48(4):882-5. Review. No abstract available.

23.

Role of CD19 signal transduction in B cell biology.

Carter RH, Wang Y, Brooks S.

Immunol Res. 2002;26(1-3):45-54. Review.

PMID:
12403344
24.

The physiologic role of CD19 cytoplasmic tyrosines.

Wang Y, Brooks SR, Li X, Anzelon AN, Rickert RC, Carter RH.

Immunity. 2002 Oct;17(4):501-14.

25.

N4 RNA polymerase II, a heterodimeric RNA polymerase with homology to the single-subunit family of RNA polymerases.

Willis SH, Kazmierczak KM, Carter RH, Rothman-Denes LB.

J Bacteriol. 2002 Sep;184(18):4952-61.

26.

Antigen receptor proximal signaling in splenic B-2 cell subsets.

Li X, Martin F, Oliver AM, Kearney JF, Carter RH.

J Immunol. 2001 Mar 1;166(5):3122-9.

29.

Changing nursing practice through research utilization: consistent support for breastfeeding mothers.

Janken JK, Blythe G, Campbell PT, Carter RH.

Appl Nurs Res. 1999 Feb;12(1):22-9.

PMID:
10048238
30.
31.

CD19 as a membrane-anchored adaptor protein of B lymphocytes: costimulation of lipid and protein kinases by recruitment of Vav.

O'Rourke LM, Tooze R, Turner M, Sandoval DM, Carter RH, Tybulewicz VL, Fearon DT.

Immunity. 1998 May;8(5):635-45.

32.

Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses.

Oliver AM, Martin F, Gartland GL, Carter RH, Kearney JF.

Eur J Immunol. 1997 Sep;27(9):2366-74.

PMID:
9341782
33.

Role of CD19 tyrosine 391 in synergistic activation of B lymphocytes by coligation of CD19 and membrane Ig.

Li X, Sandoval D, Freeberg L, Carter RH.

J Immunol. 1997 Jun 15;158(12):5649-57.

PMID:
9190913
34.

Ligation of membrane IgM stimulates a novel c-Jun amino-terminal domain kinase activity in Daudi human B cells.

Li X, Franklin CC, Kraft AS, Carter RH.

Mol Immunol. 1997 Apr;34(5):409-18.

PMID:
9293774
36.

No limits on appetite.

Janken JK, Blythe G, Campbell PT, Carter RH.

Reflections. 1996;22(3):17. No abstract available.

PMID:
9256780
37.

CD28-mediated costimulation in the absence of phosphatidylinositol 3-kinase association and activation.

Crooks ME, Littman DR, Carter RH, Fearon DT, Weiss A, Stein PH.

Mol Cell Biol. 1995 Dec;15(12):6820-8.

38.

The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity.

Fearon DT, Carter RH.

Annu Rev Immunol. 1995;13:127-49. Review.

PMID:
7542009
39.

Functional dissection of the CD21/CD19/TAPA-1/Leu-13 complex of B lymphocytes.

Matsumoto AK, Martin DR, Carter RH, Klickstein LB, Ahearn JM, Fearon DT.

J Exp Med. 1993 Oct 1;178(4):1407-17.

40.

Resonance Raman spectroscopy of the cytochrome c oxidase from Paracoccus denitrificans.

Lynch SR, Carter RH, Copeland RA.

Biochemistry. 1993 Jul 13;32(27):6923-7.

PMID:
8392865
41.

CD19 of B cells as a surrogate kinase insert region to bind phosphatidylinositol 3-kinase.

Tuveson DA, Carter RH, Soltoff SP, Fearon DT.

Science. 1993 May 14;260(5110):986-9.

PMID:
7684160
42.

CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes.

Carter RH, Fearon DT.

Science. 1992 Apr 3;256(5053):105-7.

PMID:
1373518
43.
44.

Tyrosine phosphorylation of phospholipase C induced by membrane immunoglobulin in B lymphocytes.

Carter RH, Park DJ, Rhee SG, Fearon DT.

Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2745-9.

45.

Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19.

Matsumoto AK, Kopicky-Burd J, Carter RH, Tuveson DA, Tedder TF, Fearon DT.

J Exp Med. 1991 Jan 1;173(1):55-64.

46.

Mapping of the Epstein-Barr virus and C3dg binding sites to a common domain on complement receptor type 2.

Lowell CA, Klickstein LB, Carter RH, Mitchell JA, Fearon DT, Ahearn JM.

J Exp Med. 1989 Dec 1;170(6):1931-46.

47.

Polymeric C3dg primes human B lymphocytes for proliferation induced by anti-IgM.

Carter RH, Fearon DT.

J Immunol. 1989 Sep 15;143(6):1755-60.

PMID:
2528579
48.

Immunoregulatory functions of complement: structural and functional studies of complement receptor type 1 (CR1; CD35) and type 2 (CR2; CD21).

Fearon DT, Klickstein LB, Wong WW, Wilson JG, Moore FD Jr, Weis JJ, Weis JH, Jack RM, Carter RH, Ahearn JA.

Prog Clin Biol Res. 1989;297:211-20. No abstract available.

PMID:
2531419
49.

Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes.

Carter RH, Spycher MO, Ng YC, Hoffman R, Fearon DT.

J Immunol. 1988 Jul 15;141(2):457-63.

PMID:
2968402
50.

Capillary zone electrophoresis and isotachophoresis as alternatives to chromatographic methods for purity control of synthetic peptides.

Firestone MA, Michaud JP, Carter RH, Thormann W.

J Chromatogr. 1987 Oct 16;407:363-8. No abstract available.

PMID:
3429513

Supplemental Content

Loading ...
Support Center